OneTouch SureStep Test Strip Recall: May Provide Low Blood Glucose Levels

About 14,000 packages of OneTouch SureStep Test Strips, used to measure blood glucose levels in people with diabetes, have been recalled because they could provide incorrect information about blood glucose levels.

The glucose test strip recall was announced in late last week by the FDA and the manufacturer, Lifescan. The FDA warns that glucose blood levels above 400 mg/dL can cause the strips to give falsely low glucose results.

Although there have been no reported injuries in connection the defective OneTouch SureStep glucose test strips, patients who receive inaccurately low results may give themselves too low of an insulin dose. A low insulin dose can cause poor blood glucose control and could cause the patient to be unaware of dangerously high blood glucose levels. High blood glucose levels can lead to serious injury, coma and death.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Symptoms of high blood glucose levels can include thirst, frequent urination, headaches, problems concentrating, weakness and fatigue.

The recall affects eight lots of OneTouch SureStep Test Strips sold directly to consumers and some SurestepPro Test Strips sold to healthcare facilities. The recalled lots include 100-count OneTouch SureStep Test Strips with lot numbers 2969251, 2969798, 2982369 and 2983467; and 50-count OneTouch SureStep and Medicare/Mail Order strips with lot numbers 2969795, 2982566, 2969481 and 2998193.

The lot numbers are located on the outer carton and the test strip vial. The strips were distributed nationwide between August 1, 2009 and January 28, 2010.

Users who have test strips from the recalled lots should contact LifeScan to request replacement products free of charge. Consumers who have access to glucose testing meters that use different test strips should use those meters while waiting for replacements to arrive. If no other meters are available, consumers should continue to use the recalled test strips, but should contact their healthcare professional if they get a reading of 400 mg/dL, because their blood glucose levels may actually be much higher.

The company says it has contacted healthcare facilities who used the test strips in various meters and have informed them of the problem.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns (Posted today)

The FDA has issued a safety communication warning that Zimmer Biomet CPT hip system femoral stems may increase the risk of femur fractures, calling for doctors to avoid its use when possible.

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.